PRR Share Price

Open 0.02 Change Price %
High 0.02 1 Day N/A N/A
Low 0.02 1 Week 0.00 0.00
Close 0.02 1 Month 0.00 0.00
Volume 3813004 1 Year 0.00 0.00
52 Week High 0.00
52 Week Low 0.00
PRR Important Levels
Resistance 2 0.00
Resistance 1 0.00
Pivot 0.00
Support 1 0.00
Support 2 0.00
ASX Australia Most Active Stocks
NWE 0.01 %
NWE 0.01 %
NWE 0.01 %
LYC 0.18 %
AGO 0.02 %
AGO 0.02 %
AGO 0.02 %
DUE 3.02 %
DUE 3.02 %
BUR 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
PMQ 0.03 50.00%
BYR 0.05 25.00%
BYR 0.05 25.00%
ACB 0.06 20.00%
ACB 0.06 20.00%
AIO 9.13 10.53%
AIO 9.13 10.53%
PBG 1.15 9.52%
PBG 1.15 9.52%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
ICP 0.04 -20.00%
ICP 0.04 -20.00%
MAK 0.12 -14.29%
MAK 0.12 -14.29%
More..

Prima Biomed Ltd (ASX: PRR)

PRR Technical Analysis 1
As on 20th Sep 2017 PRR Share Price closed @ 0.02 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRR Target for September
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
PRR Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.primabiomed.com.au
PRR Address
PRR
151 Macquarie Street
Level 7
Sydney, NSW 2000
Australia
Phone: 61 2 9276 1224
Fax: 61 2 9276 1284
PRR Latest News
Interactive Technical Analysis Chart Prima Biomed Ltd ( PRR ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Prima Biomed Ltd
PRR Business Profile
Prima BioMed Ltd., a biotechnology company, researches, develops, and commercializes licensed medical biotechnology products in Australia. Its lead product includes CVac, a cancer vaccine for patients in remission, which has completed two human clinical trials. The company is also developing oral vaccine against human papilloma virus, a virus associated with development of cervical cancer. Prima BioMed Ltd. is based in Sydney, Australia.